Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05168306 · ClinicalTrials.gov registry record
T2 FSL2 Weight Loss
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 43
- Enrollment target
NCT05168306 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 43 participants.
The verdict
NCT05168306 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 43 participants
- Enrollment target
Study Summary
To compare the impact of the FreeStyle Libre (FSL) 2 Flash Glucose Monitoring System to the current Diabetes Monitoring standard of care (SOC) on weight reduction in subjects with type 2 diabetes.
Interventions
- DEVICE FreeStyle Libre 2 Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-12-05 |
| Est. Completion | 2023-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05168306
The ClinicalTrials.gov registry entry for NCT05168306 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre 2 Flash Glucose Monitoring System is the first listed.
NCT05168306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05168306 about?
NCT05168306 is a clinical study titled "T2 FSL2 Weight Loss". To compare the impact of the FreeStyle Libre (FSL) 2 Flash Glucose Monitoring System to the current Diabetes Monitoring standard of care (SOC) on weight reduction in subjects with type 2 diabetes.
What is the current status of trial NCT05168306?
This trial is currently terminated. The enrollment target is 43 participants. The study started on 2021-12-05. Estimated completion is 2023-07-19.
What interventions are being tested in trial NCT05168306?
The interventions under investigation include: FreeStyle Libre 2 Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT05168306?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.